DermTech (NASDAQ:DMTK) Downgraded by Zacks Investment Research to Sell

DermTech} stock has undergone multiple analysts rating changes in the recent past.  DermTech Downgraded by Zacks Investment Research on 10/20/2021. In a note to investors, the firm issued a new rating of Sell. The analysts previously had rating of Hold.

View More DermTech (NASDAQ:DMTK) Downgraded by Zacks Investment Research to Sell